Long-term vasodilator treatment with flosequinan does not lead to hemodynamic tolerance or neurohormonal activation in severe heart failure.

Bartels, G L

Long-term vasodilator treatment with flosequinan does not lead to hemodynamic tolerance or neurohormonal activation in severe heart failure. [electronic resource] - Journal of cardiac failure Mar 1995 - 117-25 p. digital

Publication Type: Journal Article

1071-9164

10.1016/1071-9164(95)90013-6 doi


Aged
Female
Heart Failure--drug therapy
Hemodynamics--drug effects
Humans
Male
Middle Aged
Neurotransmitter Agents--blood
Quinolines--administration & dosage
Quinolones--blood
Vasodilator Agents--administration & dosage